หมวดหมู่: CISION PR Newswire – English Feeds
-
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 8, 2025 /PRNewswire/ — CARsgen Therapeu…
-
AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore
SINGAPORE, Dec. 8, 2025 /PRNewswire/ — ChemLex, a next…
-
RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION
SINGAPORE, Dec. 8, 2025 /PRNewswire/ — AI/ML health-te…
-
ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed
MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PR…
-
The 4th China International Supply Chain Expo Set for Beijing in June 2026
Sustained Worldwide Outreach Drives Greater Collaborati…
-
CARsgen’s CAR-T Product Zevor-Cel Included in China’s Commercial Health Insurance Innovative Drug Catalogue
SHANGHAI, Dec. 7, 2025 /PRNewswire/ — CARsgen Therapeu…
-
All Approved Indications of Five Akeso’s Innovative Drugs Included in China’s Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
HONG KONG, Dec. 7, 2025 /PRNewswire/ — Akeso, Inc. (99…
-
Skymizerʼs HyperThought™ Wins “Best IP/Processor of the Yearˮ and “Most Promising Productˮ at EE Awards Asia 2025
TAIPEI, Dec. 7, 2025 /PRNewswire/ — Skymizer today ann…
-
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China’s National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswi…
-
DWMaterials Accelerates Expansion into Secondary Battery and Advanced Materials Industries: “Aiming to Become a Global Market Leader”
SEOUL, South Korea, Dec. 7, 2025 /PRNewswire/ — DWMate…